Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Snehal Patel$169.5M
Market Cap • 17/04/20242006
(há 18 anos)
2020
(4 years ago)
NASDAQ
Listagem
Stafford
Sede • Texas6
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
GLSISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.